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Abstract 
Introduction: Aging in mammals, including man, is accompanied by deep changes in hormone secretion. In the majority of cases, hormone 
secretion (mostly of gonadal steroids and adrenocortical hormone dehydroepiandrosterone — DHEA) undergoes pronounced decrease. 
This decrease is thought to contribute to the progression of aging. In contrast, the secretion of gonadotropins is sharply increased in older 
adults, as a result of gonadal deficiency. Recent data indicate that gonadotropin excess may also, by itself, influence the aging process. 
The aim of the present study was to investigate the mutual relation between steroid hormones and gonadotropins and their effect on 
body mass indices in older people.
Material and methods: In a group of 100 patients (61 women and 39 men) aged over 75 years, blood serum concentrations of follicle-
stimulating hormone (FSH), luteinising hormone (LH), oestradiol (E2), testosterone, dehydroepiandrosterone sulphate (DHEAs), and 
cortisol were measured. All the patients were measured for the following: body weight (kg), body mass index (BMI) (kg/m2), and waist-
-to-height ratio (WtHR). The differences of the numerical data were evaluated by Student’s t-test and the correlations between them by 
means of Pearson’s test.
Results and conclusions: The most interesting finding of this study was to show that FSH and LH are negatively correlated with body 
mass and indices such as BMI and WtHR in older women. Because in older women the mediation of ovary is unlikely, we conclude that 
gonadotropins may influence the body mass by their direct extra-gonadal action. (Endokrynol Pol 2019; 70 (6): 484–488)
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Introduction
Aging in mammals, including man, is accompanied 
by deep changes in hormone secretion. The principal 
phenomenon is a decrease of gonadal hormone secre-
tion both in females and males, although in women this 
process is faster and more sudden than in men. A large 
decrease of gonadal hormones, as well as the adreno-
cortical hormone dehydroepiandrosterone (DHEA), 
were shown to play an important role in the progress of 
aging process in both sexes (for review see: 1–3). The fall 
of gonadal hormones leads to an increase of secretion of 
pituitary gonadotropins — follicle stimulating hormone 
(FSH) and luteinising hormone (LH) — because of a fail-
ure of the negative feedback mechanism. However, in 
contrast to the decrease of gonadal hormones, the excess 
of FSH and LH was for a long time considered to be not 
meaningful. In 1994 one of the authors of the present 
paper proposed a hypothesis that the gonadotropin 
excess might also contribute to the aging process [4]. This 
presumption is based on the earlier findings showing 
that gonadotropins exert direct extra-gonadal actions, 
which are sometimes deleterious [5–8]. More recent 
studies confirm the possibility of direct gonadotropin 
actions beyond the reproductive system. The presence 
of LH/chorionic gonadotropin receptors was revealed in 
the adrenal cortex [9–11] and the peripheral and central 
nervous system [12–14]. It was suggested that the high 
levels of LH that occur in advanced age could be involved 
in the impairment of the cognitive functions in elderly 
human subjects and in the pathogenesis of Alzheimer’s 
disease [15–18]. The FSH receptors were identified in 
osteoclasts and chondrocytes [19], and FSH was shown 
to stimulate the osteoclast differentiation [20]. The role of 
FSH in bone loss in older people beyond the oestrogen 
deficiency was hypothesised [20–22]. The possibilities of 
the direct extra-gonadal actions of gonadotropins and 
their roles in aging were recently reviewed [23].
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cortisol in women or in men. A negative correlation can 
be observed with gonadotropins and gonadal steroids 
when calculated for both genders together (FSH vs. tes-
tosterone r = –0.6728, LH vs. testosterone r = –0.5649, 
FSH vs. E2 r = –0.5968, LH vs. E2 r = –0.4916). Testos-
terone is positively correlated to E2 in both genders 
(women r = 0.3224, men r = 0.6926) and to DHEAs in 
men (r = +0.7268). Some tendency (albeit not signifi-
cant) occurs also between testosterone and cortisol in 
both genders (women r = +0.1736, men r = +0.1971). 
Moreover, E2 correlates positively with DHEAs in 
women (r = +0.3199). No significant correlations of 
cortisol concentrations and other investigated hor-
mones were found. Interesting relations were found 
between gonadotropin levels and body mass indices 
of the investigated patients. The significant negative 
correlations were observed between FSH or LH and 
body mass in the group of women (FSH, r = –0.4144, 
Fig. 1; LH, r = –0.3378; Fig. 2). In the group of women, 
the negative correlations can also be noticed between 
FSH (r = –0.34892, Fig. 3) or LH and BMI (r = –0.2689, 
Fig. 4). The similar negative correlations exist in this 
group between FSH or LH and WtHR (FSH, r = –0.3477, 
Fig. 5; LH, r = –0.2566, Fig. 6). The correlations of the 
remaining examined hormones and body mass indices 
are rather scarce. Only a negative correlation between 
testosterone and body mass in men (r = –0.3544) and 
positive correlation with WtHR in women (r = +0.3293) 
were observed. None of the investigated hormones 
except gonadotropins correlated with BMI.
Discussion and conclusions
To the best of our knowledge this is the first study 
investigating the mutual relations between steroid 
hormones and gonadotropins and their effect on body 
mass indices in very advanced age. Our findings con-
cerning FSH and LH levels in older women and men 
(higher values in women and higher elevation of FSH 
in comparison to LH in both genders) are concordant 
with the previous studies (for review see: 1, 2). The 
The aim of the present study was to investigate 
the relation between hormone levels (with special 
reference to gonadotropins) and body mass indices in 
older patients. 
Material and methods
Patients 
The project was approved by the Bioethical Committee of the 
Medical University of Lodz, decision number RNN/363/17/KE from 
21st November 2017. The study material comprised 100 patients: 61 
women (aged at the time of the investigation 76–90 years; mean age 
80.61 years) and 39 men (aged 76–88 years; mean age 79.56 years). 
All of the patients had the following measurements: body weight 
(kg), body mass index (BMI) (kg/m2), waist-to-height ratio (WtHR). 
Methods
The quantitative determinations of the following hormone levels in 
blood serum were performed: follicle-stimulating hormone (FSH), 
luteinising hormone (LH), oestradiol testosterone, dehydroepi-
androsterone sulphate (DHEAs), cortisol. Blood samples were taken 
from the cubital vein in the morning. For determinations, we used 
technology based on the competitive or sandwich chemilumines-
cence immunoassays (CLIA). The measurements were performed 
on a LIAISON XL analyser from DiaSorin Inc. (Saluggia, VC, Italy or 
Stillwater, MN, USA) using the kits produced by this company and 
dedicated to the abovementioned analyser. The differences of the 
mean values and correlations of the numerical data were evaluated 
by Student’s t-test and Pearson’s test, respectively.
Results
The mean serum concentrations of the hormones ex-
amined in the present study are presented in Table I. As 
can be seen there, the mean concentrations of FSH and 
LH are significantly higher in women in comparison 
to men (p < 0.001). In both genders the concentrations 
of FSH were higher than that of LH (p < 0.001). On 
the other hand, the mean concentrations of DHEAs 
(p < 0.05), testosterone (p < 0.001), and E2 (p < 0.001) 
are significantly higher in men as compared to women. 
FSH and LH are positively correlated between them in 
both investigated groups (women r = +0.6986, men 
r = +0.7848). In contrast, FSH and LH levels are not cor-
related significantly with testosterone, E2, DHEAs, and 
Table I. The mean body mass, body mass index (BMI), waist-to-height ratio (WtHR), and serum concentrations of hormones. 
Comparison of two group of gender by Student’s t-test
  Body mass [kg]
BMI  
[kg/m2] WtHR
FSH  
[mIU/mL]
LH  
[mIU/mL]
E2  
[pmol/L]
T  
[nmol/L]
DHEAS  
[µg/dL]
Cortisol  
[µg/dL]
Women 69.3 ± 12.72
28.5  ± 
5.14
0.59 ± 
0.07
87.9 ± 
27.17
21.2 ± 
7.53
56.5 ± 
18.88
0.79 ± 
0.43
42.5 ± 
28.84
14.9 ± 
7.35
Men 79.0 ± 10.13
28.1 ± 
3.15
0.59 ± 
0.06
23.3 ± 
24.40
8.3 ±  
7.01
113.6 ± 
36.79
12.1 ± 
5.41
58.2 ± 
36.27
17.3 ± 
5.76
p < 0.001 > 0.05 > 0.05 < 0.001 < 0.001 < 0.001 < 0.001 < 0.05 > 0.05
FSH — follicle-stimulating hormone; LH — luteinising hormone; E2 — oestradiol testosterone; DHEAS — dehydroepiandrosterone sulphate
486
O
R
IG
IN
A
L
 P
A
P
E
R
Hormones and human aging Marek Pawlikowski et al.













Figure 2. Scatter plot of correlation between body mass and 
luteinising hormone (LH) for women
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Figure 3. Scatter plot of correlation between body mass index 
(BMI) and follicle-stimulating hormone (FSH) for women
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Figure 4. Scatter plot of correlation between body mass index 
(BMI) and luteinising hormone (LH) for women
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Figure 1. Scatter plot of correlation between body mass and 
follicle-stimulating hormone (FSH) for women
Figure 6. Scatter plot of correlation between waist-to-height ratio 
(WtHR) and luteinising hormone (LH) for women
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Figure 5. Scatter plot of correlation between waist-to-height ratio 
(WtHR) and follicle-stimulating hormone (FSH) for women
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higher levels of DHEAs in men than in women are also 
concordant with earlier observations [3]. The higher 
levels of testosterone in men as compared to women 
are also obvious. Surprisingly, the mean concentration 
of E2 in men sharply exceeds the value observed in 
women. However, the same observation was done by 
Vermeulen et al. [24]. This finding can be explained by 
the higher availability of androgens (which are known 
to be the oestrogen precursors) in older men. The ob-
served correlations between the particular examined 
hormones are rather expected. In spite of the occur-
rence of LH receptors in the human adrenal cortex (see 
Introduction), no correlation between LH and cortisol 
or DHEAs was found. Saxena and Seely [25] reported 
the positive correlation between LH and with urinary 
free cortisol in postmenopausal women, but (similarly 
to us) not with blood serum cortisol levels. The most 
interesting finding of our study is the demonstra-
tion of negative correlations between gonadotropin 
levels and body mass indices in women. Our results 
suggest a negative effect of elevated gonadotropins 
on the body mass, presumably on fat deposits and 
their distribution. Because mediation of the ovary is 
unlikely in older women, we conclude that gonado-
tropins may influence the body mass by their direct 
extra-gonadal action. The lack of similar correlation 
in men may result from the well-known occurrence 
of lower gonadotropin increment during aging in this 
gender, but it may also depend on the lower number 
of investigated patients in the male group. Theoreti-
cally, the effect of gonadotropin excess on body mass 
observed in women may concern all principal body 
compartments, i.e. fat tissue, bone, and muscular sys-
tem. The knowledge on the direct effects of FSH and 
LH on the fat tissue is very limited. The direct effects 
of gonadotropins were shown in the brown fat tissue 
in rats [26] and mice [27]. Liu et al. [28] reported on the 
expression of FSH receptors in human fat tissue using 
both RT-PCR and immunohistochemistry. Recently we 
have also shown in our laboratory that human peri-
adrenal and breast fat tissue exhibits strong positive 
immunoreaction with antibodies against FSH and LH 
receptors (unpublished results). The authors quoted 
above conclude that the activation of these receptors 
activates the lipid biosynthesis, and the FSH excess is 
an important causal factor of age-related obesity [28]. 
They also observed positive correlations of FSH and 
BMI in aging subjects. However, their investigated 
groups were much younger (women 51–55 years, 
men 61–65 years) in comparison to our patients. It 
cannot be excluded that in more advanced age the 
function of gonadotropin receptors is shifted towards 
lipolysis. However, the role of FSH and LH receptors 
in the fat tissue of older subjects needs further de-
tailed studies. On the other hand, the body mass loss 
evoked by gonadotropins may partially result from 
osteoporosis accelerated by FSH (see Introduction). The 
participation of sarcopenia cannot be also excluded. 
To our knowledge there are no data on the effects of 
gonadotropins on the muscular system, although the 
FSH receptors were identified in the skeletal muscles 
[28]. Further studies concerning the effects of gonado-
tropins on body composition in larger groups of older 
people are urgently needed.
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